About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72722 record(s)
Req # A-2019-001972
Adverse Reaction Report (AER). Report number: E2B_02782262.Organization: Health Canada
November 2020
Req # A-2019-002061
Adverse Reaction Reports (AERs) for ENTYVIO. Report numbers: E2B_02910855, E2B_02916121, E2B_02918668, E2B_02903656, E2B_02913143.Organization: Health Canada
November 2020
Req # A-2019-002062
Adverse Reaction Reports (AERs) for VEDOLIZUMAB. Report numbers: E2B_02886208, E2B_02906274, E2B_02869094, E2B_02887283, E2B_02891420, E2B_02867066, E2B_02891996, E2B_02881020, E2B_02907681, E2B_02880510, E2B_02885532, E2B_02878124, E2B_02872742.Organization: Health Canada
November 2020
Req # A-2019-002070
Adverse Reaction Reports (AERs) for Hydromorphone. Report numbers: E2B_02828994, E2B_02861088, E2B_02861106, E2B_02862412, E2B_02870921, E2B_02871823, E2B_02897089, E2B_02900033, E2B_02901733.Organization: Health Canada
November 2020
Req # A-2020-000010
Adverse Reaction Reports (AERs) for LEFLUNOMIDE. Report numbers: E2B_02491832, E2B_02204747, E2B_02567212, E2B_02503771, E2B_01845887, E2B_02502767, E2B_02506771, E2B_02505305, E2B_00365584, E2B_02502696.Organization: Health Canada
November 2020
Req # A-2020-000046
Adverse Reaction Reports (AERs). Report numbers: E2B_02936075, E2B_01851910, 000731978, 000733208, E2B_02983777, E2B_02930109, E2B_02082034, E2B_02944715, 000737188.Organization: Health Canada
November 2020
Req # A-2020-000072
Adverse Reaction Reports (AERs). Report numbers: E2B_00481009, E2B_02562468, E2B_02497002, 726658, E2B_02526400, E2B_02526431, E2B_02526438, E2B_02526442, E2B_02526741, E2B_02597281, E2B_02604468, E2B_02607001, E2B_02613220, E2B_02613525,…Organization: Health Canada
November 2020
Req # A-2020-000090
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02713465, E2B_02715858, E2B_02716889, E2B_02716934, E2B_02720211, E2B_02743485, E2B_02665694, E2B_02720816, E2B_02666578, E2B_02723321, E2B_02723693, E2B_02667502,…Organization: Health Canada
November 2020
Req # A-2020-000118
Adverse Reaction Reports (AERs). Report numbers: E2B_02231544, E2B_02231553, E2B_ 02231868, E2B_02243563, E2B_02262269, E2B_02271698, E2B_02298034, E2B_02298042, E2B_02302786, E2B_02303633, E2B_02318619, E2B_02319741, E2B_02320926, E2B_02320937,…Organization: Health Canada
November 2020
Req # A-2020-000132
Adverse Reaction Reports (AERs). Report numbers: 000720865, 000721013, E2B_02260525, E2B_02263869, E2B_02263997, E2B_02264072, E2B_02271951, E2B_02260825, 000721986, 000722192, E2B_02370818, E2B_02341675.Organization: Health Canada
November 2020